Navigation Links
Buffalo Company Launches First-ever National Electronic Transaction Network to Improve Health Care Access for Uninsured and Underinsured
Date:1/31/2008

HealthTransaction Network(R) keeps costs down and improves access by

connecting health care facilities and consumers

BUFFALO, N.Y., Jan. 31 /PRNewswire/ -- HealthTransaction Network(R) is creating the first-ever nationwide health care provider network to provide routine wellness and preventive care services to underserved populations at affordable costs, the company announced today.

HealthTransaction Network connects providers and consumers using an electronic transaction network system that quickly, securely and efficiently facilitates and processes transactions between the parties. The Network operates using a shared processing infrastructure, consumer cards and a new electronic transaction terminal device located at participating provider sites.

"The Network is a win-win for health care consumers and providers," said Joseph E. Wolfson, President and CEO of HealthTransaction Network. "It reduces costs for the provider making it possible for them to offer routine medical services at more affordable rates to the consumer, thereby improving access and patient outcomes."

Participation in the Network is open to all health care providers nationwide and consumers can access and purchase services by subscribing and obtaining a card from a participating provider or employer. The cards incorporate biometric technologies to ensure patient identification (e.g., fingerprint and signature verification), and also may be used as a stored value card. Consumers will pay only a minimal processing fee to obtain a card and subscribe to the Network.

The types of services that will be available to consumers that subscribe to the Network include preventive, wellness and routine services such as physicals, dental cleanings, eye exams mammograms and x-rays. All services will be available on a per transaction basis, and consumers will also have access to generic prescriptions for as low as $7.00.

HealthTransaction Network has
'/>"/>

SOURCE HealthTransaction Network(R)
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove, Illinois
2. Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
3. P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company
4. First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II
5. Maintenance Software Company Bucks Trend, Offers Unlimited No-Charge Product Tech Support
6. Gerresheimer Finalises Purchase of Spanish Company EDP
7. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
8. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008
9. From Research to Practice: Healthfitness, Eastman Chemical Company Case Study Demonstrates Real-World Health Gains and Productivity Savings
10. Companys Award-Winning Sound Enhancement Technology Proven to Provide Superior Performance Over Other Technologies; Patent Will Enhance Able Planet, LINX AUDIO Brands
11. KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Catholics for Choice Statement on Healthcare Reform Bill 60931 1Catholics for Choice Statement on Healthcare Reform Bill 60931 2Findings show nanomedicine promising for treating spinal cord injuries 10653 1Findings show nanomedicine promising for treating spinal cord injuries 10653 2Findings show nanomedicine promising for treating spinal cord injuries 10653 3APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 60929 1APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 60929 2